Involving Hydrolase Patents (Class 435/18)
-
Patent number: 8785142Abstract: The invention relates to an arrangement, comprising a solid carrier and a matrix arranged on the solid carrier, said matrix comprising at least one enzymatically convertible or modifiable molecule and comprising at least one enzyme that can be released by the conversion or modification of the molecule, said enzyme being capable of converting at least one color-changing substrate located in the matrix and/or on the solid carrier.Type: GrantFiled: February 9, 2011Date of Patent: July 22, 2014Inventors: Georg Gübitz, Eva Sigl, Andrea Hasmann, Marc Schröder, Konstantin Schneider, Alexandra Rollett, Franz Kaufmann, Andreas Hafner
-
Publication number: 20140199705Abstract: The invention relates to polypeptides having glucanase, e.g., endoglucanase, mannanase, xylanase activity or a combination of these activities, and polynucleotides encoding them. In one aspect, the glucanase activity is an endoglucanase activity (e.g., endo-1,4-beta-D-glucan 4-glucano hydrolase activity) and comprises hydrolysis of 1,4-beta-D-glycosidic linkages in cellulose, cellulose derivatives (e.g., carboxy methyl cellulose and hydroxy ethyl cellulose) lichenin, beta-1,4 bonds in mixed beta-1,3 glucans, such as cereal beta-D-glucans or xyloglucans and other plant material containing cellulosic parts. In addition, methods of designing new enzymes and methods of use thereof are also provided. In alternative aspects, the new glucanases e.g., endoglucanases, mannanases, xylanases have increased activity and stability at increased pH and temperature.Type: ApplicationFiled: September 5, 2013Publication date: July 17, 2014Applicants: SYNGENTA PARTICIPATIONS AG, BP CORPORATION NORTH AMERICA INC.Inventors: Brian Steer, Walter Niles Callen, Shaun Healey, Derrick Pulliam
-
Patent number: 8778649Abstract: A thermophilic endo-beta-1,4-xylanase derived from Acidothermus cellulolyticus is disclosed. The xylanase exhibits xylanase activity at an optimal temperature of 90° C. and an optimal pH range of about 4.5-6.0. The isolated xylanase is useful in the hydrolysis of lignocellulosic material.Type: GrantFiled: October 16, 2012Date of Patent: July 15, 2014Assignee: The Regents of the University of CaliforniaInventors: Rebecca E. Parales, Alison M. Berry, Juanito V. Parales, Jr., Ravi D. Barabote
-
Publication number: 20140194304Abstract: Antibody-free processes are disclosed that provide accurate quantification of a wide variety of low-abundance target analytes in complex samples. The processes can employ high-pressure, high-resolution chromatographic separations for analyte enrichment. Intelligent selection of target fractions may be performed via on-line Selected Reaction Monitoring (SRM) or off-line rapid screening of internal standards. Quantification may be performed on individual or multiplexed fractions. Applications include analyses of, e.g., very low abundance proteins or candidate biomarkers in plasma, cell, or tissue samples without the need for affinity-specific reagents.Type: ApplicationFiled: January 8, 2013Publication date: July 10, 2014Applicant: BATTELLE MEMORIAL INSTITUTEInventors: Tujin Shi, Weijun Qian, Thomas L. Fillmore, Xuefei Sun, Richard D. Smith
-
Publication number: 20140193392Abstract: Methods are provided for the prognosis, diagnosis and treatment of various pathological states, including cancer, chemotherapy resistance and dementia associated with Alzheimer's disease. The methods provided herein are based on the discovery that various proteins with a high level of sialylation are shown herein to be associated with disease states, such as, cancer, chemotherapy resistance and dementia associated with Alzheimer's disease. Such methods provide a lysosomal exocytosis activity profile comprising one or more values representing lysosomal exocytosis activity. Also provided herein, is the discovery that low lysosomal sialidase activity is associated with various pathological states. Thus, the methods also provide a lysosomal sialidase activity profile, comprising one or more values representing lysosomal sialidase activity. A lysosomal sialidase activity profile is one example of a lysosomal exocytosis activity profile.Type: ApplicationFiled: August 28, 2012Publication date: July 10, 2014Applicant: ST. JUDE CHILDREN'S RESEARCH HOSPITALInventors: Ida Annunziata, Alessandra D'Azzo, Shai White-Gilbertson
-
Patent number: 8771974Abstract: Provided herein are methods of diagnosing or monitoring the treatment of abnormal glycan accumulation or a disorder associated with abnormal glycan accumulation.Type: GrantFiled: July 16, 2012Date of Patent: July 8, 2014Assignee: BioMarin Pharmaceutical Inc.Inventors: Brett E. Crawford, Jillian R. Brown, Charles A. Glass, Jim R. Beitel, Robin M. Jackman
-
Patent number: 8771975Abstract: Provided herein are methods for quantitating glutamate carboxypeptidase II activity in a biological sample, such as a skin biopsy sample, and for determining whether an agent is inhibiting GCP in a subject.Type: GrantFiled: January 5, 2012Date of Patent: July 8, 2014Assignee: The Johns Hopkins UniversityInventors: Barbara S. Slusher, Michael Polydefkis, Camilo Rojas, Marigo Stathis
-
Patent number: 8771714Abstract: Provided are systems and methods for detecting and/or measuring in vivo interstitial biological activity, processes, and or compounds in human or animal subjects.Type: GrantFiled: October 31, 2007Date of Patent: July 8, 2014Assignee: MUSC Foundation for Research DevelopmentInventors: Francis G. Spinale, Robert Stroud, Michael Looper, Anne Deschamps
-
Publication number: 20140186867Abstract: A composition comprising a main species HER2 antibody that binds to domain II of HER2 and acidic variants thereof is described. Pharmaceutical formulations comprising the composition, and therapeutic uses for the composition are also disclosed.Type: ApplicationFiled: January 23, 2014Publication date: July 3, 2014Applicant: Genentech, Inc.Inventors: REED J. HARRIS, PAUL A. MOTCHNIK
-
Publication number: 20140186868Abstract: The stabilization of a hydrolytic enzyme in a liquid preparation is to be improved through a component that stabilizes the hydrolytic enzyme. This is accomplished by a method for adapting a hydrolytic enzyme to a component that stabilizes the hydrolytic enzyme, comprising the following method steps: a) providing a hydrolytic enzyme (starting enzyme) and a component that stabilizes the hydrolytic enzyme and that comprises a reversible inhibitor of the hydrolytic enzyme; b) changing the amino acid sequence of the hydrolytic enzyme in at least one position, by substitution, deletion or insertion; c) determining the relative activity of the hydrolytic enzyme from step b) and the relative activity of the starting enzyme in a liquid preparation; d) selecting the hydrolytic enzyme that has a reduced relative activity by comparison with the relative activity of the starting enzyme.Type: ApplicationFiled: March 6, 2014Publication date: July 3, 2014Applicant: Henkel AG & Co., KGaAInventors: Petra Siegert, Stefan Evers, Marion Merkel, Nina Mussmann, Hendrik Hellmuth, Timothy O'Connell, Karl-Heinz Maurer, Ulrich Schwaneberg, Felix Jakob, Ronny Martinez, Brian Laufs, Ayhan Aydemir, Thomas Weber
-
Publication number: 20140178330Abstract: Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations and uses thereof.Type: ApplicationFiled: December 28, 2012Publication date: June 26, 2014Inventors: Ge Wei, H. Michael Shepard, Qiping Zhao, Robert James Connor
-
Publication number: 20140178912Abstract: An exemplary multimodal chromatographic medium of the invention includes one or more strong anion exchange, weak anion exchange, strong cation exchange and/or weak cation exchange binding sites in combination with one or more reverse phase and/or hydrophilic interaction chromatography binding site. In an exemplary embodiment, the sites interact with one or more glycans in a mixture of glycans in a manner that allows separation of glycans in the mixture and analysis of the glycan mixture. The media are incorporated into devices and systems for chromatographic analysis. Also provided are methods of using the multimodal media of the invention to analyze glycans.Type: ApplicationFiled: December 21, 2012Publication date: June 26, 2014Inventors: Xiaodong LIU, Udayanath AICH, Christopher A. POHL
-
Publication number: 20140178913Abstract: Methods and compositions for detecting molecular interactions are provided. Aspects of the invention include the use of a reduced affinity enzyme complementation reporter system. Also provided are systems and kits for use in practicing embodiments of the methods.Type: ApplicationFiled: September 24, 2013Publication date: June 26, 2014Inventors: Tom Wehrman, Helen M. Blau
-
Patent number: 8758989Abstract: A diagnostic test kit for detecting the presence or quantity of an enzyme or enzyme inhibitor is provided. The diagnostic kit utilizes substrate conjugates to facilitate the detection of the enzyme or enzyme inhibitor via direct detection of the substrate and/or a product formed in an enzyme-catalyzed reaction of the substrate. The substrate conjugates include a substrate joined (e.g., covalently bonded, physically adsorbed, etc.) to a reporter. In one embodiment, for example, a peptide, protein, or glycoprotein substrate is joined to a reporter (e.g., dyed latex particle). In this embodiment, the substrate provides a cleavage target for an enzyme. Specifically, upon contacting the substrate conjugate, the enzyme catalyzes a reaction with the substrate and forms a product conjugate that includes the product of the enzyme catalyzed reaction joined to the reporter. The signal exhibited by the reporters may then be used to indicate the presence or quantity of an enzyme or enzyme inhibitor within the test sample.Type: GrantFiled: April 6, 2006Date of Patent: June 24, 2014Assignee: Kimberly-Clark Worldwide, Inc.Inventor: Xuedong Song
-
Publication number: 20140162299Abstract: The invention relates to methods and kits for the analysis of the sialylation of gluco-proteins. The samples of gluco-protein are incubated separately under three conditions: with beta-galactosidase, with beta-galactosidase+alpha-sialidase, and without an enzyme. After the enzyme treatment, high performance anion exchange chromatography with pulsed amperometric detection (HPAEC PAD) is used to make a quantitative determination of the total galactose in the sample, the non sialylated galactose and the exogenous galactose in the medium. The determination of said values makes it possible to deduce the percentage of sialylation of the gluco-protein.Type: ApplicationFiled: July 5, 2012Publication date: June 12, 2014Applicant: GRIFOLS, S.A.Inventors: Zihao Wang, Jessica Sloan, Kevin Wee
-
Publication number: 20140162301Abstract: The present invention relates to a method for determining the presence or absence of a microorganism, said method including the steps of: 1) providing an enclosure containing a liquid or semi-solid phase consisting of a biological medium capable of containing a living form of said microorganism, nutritional elements, and an enzymatic substrate which is specific to said microorganism and which can be metabolised into at least one VOC metabolite, and a gaseous phase adjacent to said liquid or semi-solid phase; 2) exposing at least said liquid or semi-solid phase to conditions that are propitious for said microorganism to metabolise said enzymatic substrate into a molecule of said VOC metabolite; and 3) determining, by optical transduction, the presence or absence of said VOC metabolite, characterised in that the latter interacts with a nanoporous matrix, said matrix being implemented in a form that is separate from said enzymatic substrate, and in that the detection, by optical transduction, of a change in theType: ApplicationFiled: June 27, 2012Publication date: June 12, 2014Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVESInventors: Pierre Marcoux, Mathieu Dupoy, Laure-Hélène Guillemot, Thu-Hoa Tran-Thi
-
Patent number: 8748141Abstract: The present invention relates to methods for producing high levels of alcohol during fermentation of plant material, and to the high alcohol beer produced. The method can include fractionating the plant material. The present invention also relates to methods for producing high protein distiller's dried grain from fermentation of plant material, and to the high protein distiller's dried grain produced. The method can include drying a co-product by ring drying, flash drying, or fluid bed drying. The present invention further relates to reduced stack emissions from drying distillation products from the production of ethanol.Type: GrantFiled: March 25, 2013Date of Patent: June 10, 2014Assignee: Poet Research, Inc.Inventors: Stephen M. Lewis, Shon Erron Van Hulzen
-
Patent number: 8748159Abstract: A rapid method for the quantitation of various live cell types is described. This new cell fluorescence method correlates with other methods of enumerating cells such as the standard plate count, the methylene blue method and the slide viability technique. The method is particularly useful in several applications such as: a) quantitating bacteria in milk, yogurt, cheese, meat and other foods, b) quantitating yeast cells in brewing, fermentation and bread making, c) quantitating mammalian cells in research, food and clinical settings. The method is especially useful when both total and viable cell counts are required such as in the brewing industry. The method can also be employed to determine the metabolic activity of cells in a sample. The apparatus, device, and/or system used for cell quantitation is also disclosed.Type: GrantFiled: October 28, 2011Date of Patent: June 10, 2014Assignee: GenPrime, Inc.Inventors: James E. Fleming, Jason Buck Somes, Darby McLean, Jerad R. Holcomb
-
Publication number: 20140154675Abstract: Compounds having chemiluminescent flash and glow properties. Also disclosed are methods using the compounds to generate light, detect and/or quantify enzymes, antigens, and/or nucleic acids. Also disclosed are kits relating to these compounds.Type: ApplicationFiled: April 30, 2012Publication date: June 5, 2014
-
Publication number: 20140154721Abstract: The invention involves the development of a substrate and assay procedure for the scientific measurement of cellulase in admixture with other enzymes active on cellulose or 1,4-?-D-cello-oligosaccharides, or in various levels of purity of the cellulase. This substrate being characterised by the fact that it contains at least 2 glucose units linked ?-1,4-, with the reducing end glucose unit linked ?- or ?- to a compound which exhibits an optically measurable change on cleavage of the bond between it and the adjacent D-glucosyl residue and the non-reducing terminal D-glucosyl unit is covalently linked to a blocking substituent which inhibits cleavage by exo-acting enzymes of the bond between the terminal and non-reducing end, penultimate D-glucose unit.Type: ApplicationFiled: November 27, 2013Publication date: June 5, 2014Inventors: Barry V. McCleary, David Peter Mangan
-
Patent number: 8741597Abstract: A reaction medium for detecting and/or identifying Staphylococcus aureus bacteria, comprising a combination of two enzymatic substrates for alpha-glucosidase.Type: GrantFiled: October 7, 2009Date of Patent: June 3, 2014Assignee: BiomérieuxInventors: Sylvain Orenga, Denis Robichon
-
Patent number: 8741307Abstract: The present invention embraces hybrid Prosthecobacter-eukaryotic tubulin proteins and use thereof for identifying agents that modulate the activity of tubulin.Type: GrantFiled: April 19, 2010Date of Patent: June 3, 2014Assignee: Trustees of Dartmouth CollegeInventors: F. Jon Kull, Jared C. Cochran
-
Patent number: 8741592Abstract: The present invention provides methods of screening an agent for an activity in an isolated organ, e.g., eye, from a teleost, e.g., zebrafish. Methods of isolating eyes from zebrafish are provided. Methods of screening an agent for an ocular activity in the isolated eye are provided. Methods of screening an agent for an ocular activity in a model of ocular disease or disorder are provided. Methods of screening an agent for an ocular activity in the isolated eye and for screening the agent for cell death and/or toxic activity in the eye or other organ or tissue are provided. The invention further provides high throughput methods of screening agents for an activity in isolated eyes of zebrafish in multi-well plates.Type: GrantFiled: January 4, 2013Date of Patent: June 3, 2014Assignee: Phylonix Pharmaceuticals, Inc.Inventors: Patricia McGrath, Wen Lin Seng
-
Publication number: 20140147873Abstract: In various embodiments a system is provided that displays heterologous proteins on the surface of a Gram-positive microorganism. In certain embodiments the system displays proteins using a sortase transpeptidase to covalently anchor proteins to the cell wall of the microbe. Novel bacterial strains are provided to exploit this system to display cellulase enzymes and multi-enzyme complexes on the surface of Gram-positive microorganisms (e.g., Bacillus subtilis) through their non-covalent interaction with a scaffoldin protein that is covalently anchored to the cell wall by the sortase transpeptidase. The surface displayed protein complexes contain enzymes capable of degrading cellulose into its component sugars at accelerated rates as compared to solutions of purified enzymes.Type: ApplicationFiled: February 29, 2012Publication date: May 29, 2014Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIAInventors: Robert T. Clubb, Timothy Anderson
-
Publication number: 20140147431Abstract: The present disclosure provides methods of converting white adipose tissue to brown adipose tissue in an individual, generally involving modulating desnutrin-mediated lipolysis in adipocytes in the individual. The present disclosure further provides methods for treating obesity. The present disclosure further provides methods of identifying an agent that increases the level and/or activity of desnutrin in an adipocyte.Type: ApplicationFiled: September 16, 2011Publication date: May 29, 2014Applicant: The Regents of the University of CaliforniaInventors: Hei Sook Sul, Maryam Ahmadian
-
Publication number: 20140147874Abstract: The present invention relates to the field of biomarkers. More specifically, the present invention relates to biomarkers useful in diagnosing cardiac ischemia. In a specific embodiment, a method for diagnosing acute cardiac ischemia in a patient comprises the steps of (a) measuring the levels of one or more post-translationally modified and unmodified serum albumin peptides in a sample collected from the patient using SRM-MS, wherein the post-translationally modified peptides are phosphorylated and/or cysteinylated; (b) comparing the levels of the measured one or more post-translationally modified serum albumin peptides to the levels of the measured one or more unmodified serum albumin peptides; and (c) correlating the compared levels to a patient having ACI or to a patient not having ACI, thereby providing the diagnosis.Type: ApplicationFiled: March 5, 2012Publication date: May 29, 2014Applicant: The Johns Hopkins UniversityInventor: Catherine Cotter
-
Publication number: 20140141017Abstract: The present invention provides methods and compositions for identifying compounds which inhibit ApoCI and which are useful in the treatment or prevention of atherosclerosis, plaque rupture, apoptosis, or myocardial infarction. The invention further provides methods for treating subjects suffering from or at risk of developing atherosclerosis, plaque rupture, apoptosis, or myocardial infarction. The invention further provides methods for diagnosing subjects at suffering from or at risk of developing treatment or prevention of atherosclerosis, plaque rupture, apoptosis, or myocardial infarction.Type: ApplicationFiled: November 14, 2013Publication date: May 22, 2014Applicant: THE JOHNS HOPKINS UNIVERSITYInventors: Subroto Chatterjee, Peter O. Kwiterovich
-
Publication number: 20140134158Abstract: The disclosure provides compositions and methods for detecting and predicting acquired resistance to anti-EGFR treatment in colorectal cancers. Also provided are compositions and methods of preventing, reversing or delaying the acquired resistance. The present disclosure also provides kits for use in the methods described herein.Type: ApplicationFiled: May 21, 2013Publication date: May 15, 2014Inventors: Alberto Bardelli, Federica Di Nicolantonio, Salvatore Siena
-
Publication number: 20140134656Abstract: The present invention relates to a method for detecting the presence of carbapenemase-producing bacteria in a sample, said method comprising the steps of: a) performing cell lysis on a test sample in order to obtain an enzymatic suspension; b) reacting a fraction of the enzymatic suspension obtained in step a) with a reagent kit, said reagent kit comprising —a carbapenemase substrate selected from the group consisting of carbapenems and cephamycins, —a pH color indicator which will change color when the pH of the reaction mixture is comprised between 6.4 and 8.4, wherein a color change after step b) indicates the presence of carbapenemase-producing bacteria in the test sample. The invention also relates to a reagent kit, to a microtiter plate and to their uses in detecting the presence of carbapenemase producers in a test sample.Type: ApplicationFiled: June 21, 2012Publication date: May 15, 2014Applicants: ASSISTANCE PUBLIQUE HOPITAUX DE PARIS, INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE PARIS SUD (PARIS 11)Inventors: Laurent Dortet, Patrice Nordmann, Laurent Poirel
-
Publication number: 20140127735Abstract: The present disclosure provides nuclear magnetic resonance (NMR) methods for characterizing mixtures of N-linked glycans. Without limitation, methods of the present disclosure may be useful in characterizing monosaccharide composition, branching, fucosylation, sulfation, phosphorylation, sialylation linkages, presence of impurities and/or efficiency of a labeling procedure (e.g., labeling with a fluorophore such as 2-AB). In certain embodiments, the methods can be used quantitatively. In certain embodiments, the methods can be combined with enzymatic digestion to further characterize glycan mixtures.Type: ApplicationFiled: January 14, 2014Publication date: May 8, 2014Applicant: Momenta Pharmaceuticals, Inc.Inventors: Ian Christopher Parsons, Jonathan Lansing, Daniela Becatti, Scott Bailey, Carlos J. Bosques
-
Publication number: 20140127235Abstract: Disclosed herein are novel methods for controlling blood pressure that involve targeting HK alpha. Also, disclosed are novel compositions for treating elevated blood pressure that include administering an agent that disrupts HK alpha expression or activity. Methods of screening novel antihypertensives are disclosed as well.Type: ApplicationFiled: April 6, 2012Publication date: May 8, 2014Inventor: Charles Wingo
-
Publication number: 20140127712Abstract: Provided herein are assays and in vitro methods to determine susceptibility to a drug effective against a pathogenic bacteria, for example, a pathogenic Mycobacteria, that has a beta-lactamase activity. An excitation wavelength is delivered to a biological sample obtained from a subject having an infection from the pathogenic bacteria in the presence of a beta-lactamase substrate. The intensity of a signal, such as a fluorescent, luminescent or colorimetric signal, at an emission wavelength of a product of the beta-lactamase on the subject is correlated to drug susceptibility. Also provided is an assay system for monitoring drug susceptibility of a pathogenic bacteria comprising color-producing substrates for a beta-lactamase of the pathogenic bacteria, an assay device for visibly detecting a product of the beta-lactamase on the substrate thereof and a reader configured to quantify the visibly detected product.Type: ApplicationFiled: October 2, 2013Publication date: May 8, 2014Inventors: Jeffrey D. Cirillo, Jianghong Rao
-
Publication number: 20140127732Abstract: The present invention provides a test device for indicating the presence, concentration and effectiveness of chemical and biological agents. The test device interacts with the target agent producing a detectable signal indicating the presence, concentration and effectiveness of the agent. The test device includes a first carrier which changes color consequent to interaction with the target agent in proportion to the concentration of the target agent. The test device includes a second carrier which remains unreacted and unchanged in color in the presence of the target agent. The second carrier serves as an integrated reference to which the color change of the first carrier is compared.Type: ApplicationFiled: November 16, 2011Publication date: May 8, 2014Inventors: Monika Felten, Juli Patricia Hood
-
Patent number: 8715952Abstract: In general, the present invention provides a reliable assay for the quantitative determination of p-aminophenol in an aqueous sample. More particularly, the present invention provides a rapid enzyme-based assay for the quantitative determination of acetaminophen in a sample. The assay employs a xylenol chromophore and a catalyst that is preferably a weak oxidizer. The assay provides reliable results in the presence or absence of N-acetylcystiene (NAC) and can therefore be used to monitor acetaminophen levels during NAC treatment. Methods and kits for determining acetaminophen concentration in an aqueous sample are also provided.Type: GrantFiled: July 9, 2012Date of Patent: May 6, 2014Assignee: Sekisui Diagnostics LLCInventors: Michael Bulger, Jan Holinsky
-
Patent number: 8716496Abstract: Substituted sulfonated coumarins are expressed in the general formula (I), where: R1 is H, OH, or a substituted or unsubstituted, straight or branched C1-C6 alkyl radical, or —COR4, or —COOR4, or —CONHR4, R2 is H or a halogen, in particular fluorine, or a substituted or unsubstituted, straight or branched C1-C6 alkyl radical, or —COR4, or —COOR4, or —CONHR4, R1 and R2 being capable of together forming a ring, such as a substituted or unsubstituted aryl or furane, R3 is H or a halogen, in particular fluorine, or a substituted or unsubstituted, straight or branched C1-C6 alkyl radical, or —COR4, or —COOR4, or —CONHR4, where R4 is H, or a substituted or unsubstituted, straight or branched C1-C6 alkyl radical, or a substituted or unsubstituted aryl, and M is Na or K.Type: GrantFiled: September 16, 2011Date of Patent: May 6, 2014Assignees: Universite de StrasbourgInventors: Antoine Drevelle, Sylvain Ladame, Majdi Najah, Estelle Mayot
-
Patent number: 8716344Abstract: The present invention relates to compounds of the following formula wherein R3 is a fluorescent tag. Another aspect of the invention provides an assay for determining the inhibitory effect of a test compound on an HDAC protein comprising: incubating the HDAC protein with a substrate of the above formula in the presence of a test compound; and determining the activity of the HDAC protein.Type: GrantFiled: August 11, 2010Date of Patent: May 6, 2014Assignees: President and Fellows of Harvard College, Dana-Farber Cancer Institute, Inc.Inventors: Ralph Mazitschek, James Elliot Bradner
-
Patent number: 8715953Abstract: The invention relates to methods and products associated with analyzing and monitoring heterogeneous populations of sulfated polysaccharides. In particular therapeutic heparin products including low molecular weight heparin products and methods of analyzing and monitoring these products are described.Type: GrantFiled: November 1, 2013Date of Patent: May 6, 2014Assignee: Momenta Pharmaceuticals, Inc.Inventors: Ganesh Kaundinya, Zachary Shriver, Mallikarjun Sundaram, Yi-wei Qi, Ram Sasisekharan
-
Patent number: 8715993Abstract: A thermostable glycosidase enzymes derived from various Thermococcus, Staphylothermus and Pyrococcus organisms is disclosed. The enzymes are produced from native or recombinant host cells and can be utilized in the food processing industry, pharmaceutical industry and in the textile industry, detergent industry and in the baking industry.Type: GrantFiled: July 13, 2012Date of Patent: May 6, 2014Assignee: BP Corporation North America Inc.Inventors: Edward J. Bylina, Ronald V. Swanson, Eric J. Mathur, David E. Lam
-
Patent number: 8709740Abstract: A device having a substrate and an enzyme attached to the substrate. The substrate has a polymeric surface having at least two conductivity states. A minimum voltage that does not cause a redox reaction in the enzyme may be applied to the polymeric surface to change the conductivity state of the surface. A method of controlling enzyme activity by providing the above substrate with polymeric surface, attaching an enzyme to the substrate, and altering the conductivity state of the polymeric surface. Changing the conductivity of the polymer can change the activity of the enzyme.Type: GrantFiled: August 11, 2005Date of Patent: April 29, 2014Assignee: The United States of America, as represented by the Secretary of the NavyInventors: Brett D. Martin, Luminita M. Velea, Banahalli Ratna, Bruce P. Gaber
-
Publication number: 20140113321Abstract: Compositions, kits, and methods for detecting cellulolytic microorganisms in a sample are disclosed herein. In some embodiments cellulolytic microorganisms are detected by detecting the presence of a secreted enzyme, such as but not limited to cellobiohydrolase.Type: ApplicationFiled: August 7, 2012Publication date: April 24, 2014Applicant: EMPIRE TECHNOLOGY DEVELOPMENT LLCInventors: Ayyappan Nair, Ramya Govindaswamy, Sunilkumar Sukumaran, Madhuri Subbiah, Kannan Thanukrishnan, Ganesh Sambasivam, Ravindra Chandrappa, Ajay Bharadwaj
-
Patent number: 8703462Abstract: An enzyme preparation is described that includes a non-specific nuclease and a T7 Endo I mutant in a unit ratio of less than 1:200. This enzyme preparation may be used to generate double-stranded DNA fragments of a size suitable for DNA sequencing. The ends of the fragments can be readily modified as necessary to ligate adaptors or individual nucleotides to one strand of the double-stranded DNA fragments.Type: GrantFiled: February 3, 2010Date of Patent: April 22, 2014Assignee: New England Biolabs, Inc.Inventors: Pei-Chung Hsieh, Chudi Guan
-
Publication number: 20140106385Abstract: Described are methods and systems for testing lumens of cannulated delivery components or assemblies thereof that may be used to deliver cells to a patient. Test cells are contacted with walls of the lumens and/or liquids that contact walls of the lumens, potentially over an incubation period. The test cells are then assessed for an effect of the wall contact, or the liquid contact, on at least one and preferably multiple characteristics of the test cells such as innate immune response, metabolic activity, viability, cytotoxic response, and/or motility. Methods and systems as described can be used in the development and/or manufacture of cannulated delivery devices, for example providing specifications for design or process inputs or outputs, design or process validations, and/or device lot approvals. Also described are devices or products produced in accordance with such methods and systems.Type: ApplicationFiled: September 26, 2013Publication date: April 17, 2014Inventors: Niraj Ramachandran, Frank J. Fischer, JR., Michael C. Hiles, Neal E. Fearnot
-
Publication number: 20140107044Abstract: The invention provides compounds for selectively inhibiting glycosidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds. The invention also provides methods of treating diseases and disorders related to deficiency or overexpression of O-GlcNAcase, accumulation or deficiency of O-GlcNAc.Type: ApplicationFiled: March 16, 2012Publication date: April 17, 2014Applicants: Merck Sharp & Dohme Corp., Alectos Therapeutics Inc.Inventors: Ernest J. McEachern, David J. Vocadlo, Yuanxi Zhou, Craig A. Coburn, Kun Liu, Harold G. Selnick
-
Patent number: 8697382Abstract: An object of the present invention is to provide a method of identifying metallo-?-lactamase-producing bacteria, particularly, a method of conveniently identifying an IMP or VIM type. According to the present invention, there is provided a method of detecting metallo-?-lactamase-producing bacteria, comprising spotting a compound (I) onto a surface of a solid medium coated with the bacteria to be tested, spotting 3 types of ?-lactam agents at 3 respective positions different from the spot of the compound (I), culturing the solid medium, and then detecting the metallo-?-lactamase-producing bacteria based on the shape of an inhibition zone formed around the spot of each of the ?-lactam agents. There is further provided a method of identifying an IMP or VIM type of the metallo-?-lactamase-producing bacteria.Type: GrantFiled: March 31, 2010Date of Patent: April 15, 2014Assignee: Meiji Seika Pharma Co., Ltd.Inventor: Akihiro Morinaka
-
Patent number: 8696567Abstract: The present invention discloses a bedside or point of care assay for properly positioning a feeding tube in the stomach of a patient based on detecting the presence of a hydrolytic enzyme found in the stomach by an ester substrate which can be impregnated on a pH strip. The application of this test reduces the risk of tube misplacement and the resulting harm to the patient that occurs in the event of tube misplacement.Type: GrantFiled: December 1, 2010Date of Patent: April 15, 2014Assignee: Ingenza Ltd.Inventors: Reuben Carr, Lucy Farley
-
Patent number: 8697380Abstract: The invention relates to a method for selecting compounds having a modulating effect on the activation state of a dimer of VFT-domain proteins expressed in cell membranes present in a measuring medium, said dimer consisting of a first protein and of a second protein, said proteins being identical or different, wherein this method comprises the following steps: (a) labeling the first and second proteins in the N-terminal portion of their VFT domains with the members of a pair of FRET partners, the Förster radius (R0) of said pair being between 20 and 55 ?; (b) measuring the FRET signal in the absence and in the presence of the test compound within a predetermined time window; (c) selecting the test compound as a modulating compound if a difference in FRET signal in the absence and in the presence of test compound is measured in step (b). The invention can be used in the search for new medicaments and new taste modulators.Type: GrantFiled: April 29, 2010Date of Patent: April 15, 2014Assignees: CIS Bio International, Centre National de la Recherche ScientifiqueInventors: Etienne Doumazane, Jurriaan Zwier, Eric Trinquet, Jean-Phillippe Pin
-
Patent number: 8697383Abstract: The object of the present invention is to provide a fluorescent substrate for detecting the enzymatic activity of a nitrile-related enzyme. The present invention provides a compound represented by formula (I) and a fluorescent substrate for detecting the enzymatic activity of a nitrile-related enzyme, which comprises the compound.Type: GrantFiled: May 25, 2011Date of Patent: April 15, 2014Assignees: Mitsubishi Rayon Co., Ltd., The University of TokyoInventors: Yasuteru Urano, Tetsuo Nagano, Tomoe Ohta, Fujio Yu
-
Publication number: 20140099655Abstract: The present invention provides compounds and methods for assaying activities of enzymes such as histone deacetylases and histone acetyltransferases. In some embodiments, the methods may be performed in one step. The compounds described herein features peptide-based compounds having at least one blocked lysine or arginine residue which are coupled to reporter moieties. The methods described herein involve reacting a compound described herein with an enzyme, such as a histone deacetylase enzyme or a histone acetyltransferase enzyme, and an endopeptidase that recognizes basic amino acids to release the reporter moiety which may be subsequently detected.Type: ApplicationFiled: November 26, 2013Publication date: April 10, 2014Applicant: Promega CorporationInventors: Thomas Kirkland, Andrew L. Niles, Martha O'Brien, Carolyn Woodroofe Hitko
-
Patent number: 8691795Abstract: A process for preparing an oligosaccharide derivative from an oligosaccharide mixture, the process being characterized in that the process comprises the steps of (a) introducing a lipophilic group into oligosaccharides of the mixture to obtain a mixture of oligosaccharide derivatives, and (b) treating the oligosaccharide derivative mixture by serotonin affinity column chromatography.Type: GrantFiled: November 20, 2012Date of Patent: April 8, 2014Assignee: Glytech, Inc.Inventors: Kazuaki Kakehi, Mitsuhiro Kinoshita, Yuki Matsuno
-
Publication number: 20140088156Abstract: The present invention provides compounds for the inhibition of soluble epoxide hydrolase and associated disease conditions.Type: ApplicationFiled: February 14, 2012Publication date: March 27, 2014Applicant: The Regents of the University of CaliforniaInventors: Bruce D. Hammock, Sung Hee Hwang, Aaron T. Wecksler, Christophe Morisseau